August 11, 2020
Ed Yaworski has served as VP, Pharmaceutical Development of Genevant Sciences Corporation since July 2019. Previously, he was Head of Pharmaceutical Development from Genevant’s inception in April 2018. Prior to joining Genevant, Ed directed and led CMC activities at Arbutus Biopharma. He brings nearly 30 years of experience in the pharmaceutical industry, including 18 years working with nucleic acid delivery systems. Ed is an inventor of leading lipid nanoparticle delivery technology used in more than a dozen clinical trials. Ed holds an MSc. In Chemistry from the University of Manitoba.